4037 related articles for article (PubMed ID: 6605801)
1. Functional consequence of variation in melanoma antigen expression.
Zehngebot LM; Alexander MA; Guerry D; Cines DB; Mitchell K; Herlyn M
Cancer Immunol Immunother; 1983; 16(1):30-4. PubMed ID: 6605801
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.
Guerry D; Alexander MA; Herlyn MF; Zehngebot LM; Mitchell KF; Zmijewski CM; Lusk EJ
J Clin Invest; 1984 Jan; 73(1):267-71. PubMed ID: 6606651
[TBL] [Abstract][Full Text] [Related]
3. Functional characteristics and differential expression of class II DR, DS, and SB antigens on human melanoma cell lines.
Pollack MS; Chin-Louie J; Moshief RD
Hum Immunol; 1984 Feb; 9(2):75-87. PubMed ID: 6607912
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
5. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
6. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
7. Expression of cell surface antigens during allogeneic response studies with monoclonal antibodies to a polymorphic marker of activated lymphocytes and HLA class I and class II antigens.
Wollman EE; Kalil J
Tissue Antigens; 1983 Jul; 22(1):37-41. PubMed ID: 6225221
[TBL] [Abstract][Full Text] [Related]
8. Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma.
Hersey P; Murray E; Grace J; McCarthy WH
Pathology; 1985 Jul; 17(3):385-91. PubMed ID: 2866482
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR and melanoma-associated antigen (p97) expression during the cell cycle in human melanoma cell lines, and the effects of recombinant gamma-interferon: two-color flow cytometric analysis.
Kameyama K; Takezaki S; Kanzaki T; Nishiyama S
J Invest Dermatol; 1986 Sep; 87(3):313-8. PubMed ID: 3090158
[TBL] [Abstract][Full Text] [Related]
11. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens.
de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S
Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398
[TBL] [Abstract][Full Text] [Related]
12. Expression of MHC class II and Tac antigens on IL2-activated human T cell clones that can stimulate in MLR, AMLR, PLT and can present antigen.
Triebel F; de Roquefeuil S; Blanc C; Charron DJ; Debre P
Hum Immunol; 1986 Mar; 15(3):302-15. PubMed ID: 2420767
[TBL] [Abstract][Full Text] [Related]
13. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
[TBL] [Abstract][Full Text] [Related]
14. Response of human T lymphocytes to phytohemagglutinin (PHA) after sequential depletion of monocytes, HLA-DR+, Leu11a+, and Leu7+ cells.
Ulmer AJ; Scholz W; Ernst M; Flad HD
Immunobiology; 1985 Dec; 170(5):419-33. PubMed ID: 2936677
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Carrel S; Schmidt-Kessen A; Giuffrè L
Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
[TBL] [Abstract][Full Text] [Related]
16. Alloactivated HLA class II-positive T-cell lines induce IL-2 reactivity but lack accessory cell function in mixed leukocyte culture.
Odum N; Dickmeiss E; Hofmann B; Jakobsen BK; Morling N; Platz P; Ryder LP; Geisler C; Svejgaard A
Hum Immunol; 1989 Jun; 25(2):135-48. PubMed ID: 2525543
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
Masuyama J; Minato N; Kano S
J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
[TBL] [Abstract][Full Text] [Related]
18. Alloactivated long-term cultured human T lymphocytes express both HLA-DR and SB antigens but lack lymphocyte stimulation capacity.
Pawelec G; Blaurock M; Schneider EM; Shaw S; Wernet P
Eur J Immunol; 1982 Nov; 12(11):967-72. PubMed ID: 6983971
[TBL] [Abstract][Full Text] [Related]
19. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
